So, if you can believe these dumbarse numnuts, the filings state
Cemp valued at 500 million
New Company 520 million
Cemp gets 48% New Company 52%
Without synergies this would put the stock at $9.00 valuation..
That is of course, if you believe the valuations..
As far as Cemp, the FDA break is a bit misleading. The trial size has been cut down but the intravenous indication has been removed. Oral is easier for approval, but intravenous would be from extremely sick patients in hospitals and would be a higher price point.
Oral would still be a second line antibiotic behind a generic.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM